Menicon Co., Ltd.

7780.T
Medical Instruments & Supplies
2026/08/23 Updated
Market Cap: $896.8M (¥142.6B)
Stock Price: $12.08 (¥1,920)
Exchange Rate: 1 USD = ¥158.98

[Menicon] Stock-based Compensation Stock Options Grant | June 2026

Menicon has granted a total of 158 new stock acquisition rights to directors of its subsidiaries, with an exercise period scheduled from March 31, 2027, to March 30, 2077.

Importance:
Page Updated: June 26, 2026
IR Disclosure Date: June 26, 2026

Key Figures

  • Total number of new stock acquisition rights: 158 units
  • Number of shares granted: 15,800 shares
  • Exercise price: 1 yen

AI要約

Grant of Stock-based Compensation Stock Options

Menicon resolved at the Board of Directors meeting held on June 26, 2026, to grant 158 units of the 36th new stock acquisition rights to directors of its subsidiaries. The total number of shares granted is 15,800, with an exercise period from March 31, 2027, to March 30, 2077. The exercise price is set at 1 yen, aiming to boost management motivation and enhance corporate value. Details of the grant and adjustment provisions are also specified.

Future Outlook and Impact on Shareholders

This stock option grant demonstrates the management's commitment to long-term corporate value improvement and may contribute to increased management motivation and sustainable growth for shareholders. The granted stock acquisition rights are expected to appreciate in value through stock price increases and improved performance during the exercise period. Additionally, conditions and adjustment provisions for the grant may entail considerations regarding share dilution and impact on shareholder value.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Menicon Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →